Attached files

file filename
S-1 - S-1 - Onconova Therapeutics, Inc.a15-21355_1s1.htm
EX-23.1 - EX-23.1 - Onconova Therapeutics, Inc.a15-21355_1ex23d1.htm

Exhibit 5.1

 

GRAPHIC

 

Suite 400

301 Carnegie Center

Princeton, NJ 08543-5276

609.452.0808

Fax 609.452.1147

 

October 20, 2015

 

Onconova Therapeutics, Inc.

375 Pheasant Run

Newtown, PA 18940

 

Re:                             Securities Registered under Registration Statement on Form S-1

 

Ladies and Gentlemen:

 

This opinion is being furnished to you in connection with the Registration Statement on Form S-1 (the “Registration Statement”), including the prospectus that is part of the Registration Statement (the “Prospectus”), filed by Onconova Therapeutics, Inc., a Delaware corporation (the “Company”), with the U.S. Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933 (the “Act”).  We are rendering this opinion in connection with the resale by the selling stockholder of the Company, Lincoln Park Capital Fund, LLC (the “Selling Stockholder”), of up to an aggregate of 5,200,000 shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), consisting of 1,046,755 outstanding shares of Common Stock that have been issued (the “Outstanding Shares”) and up to an additional 4,153,245 shares issuable (the “Issuable Shares,” and together with the Outstanding Shares, the “Shares”) pursuant to that certain Purchase Agreement dated October 8, 2015 between the Company and the Selling Stockholder (the “Purchase Agreement”).

 

We have acted as your counsel in connection with the preparation of the Registration Statement.  We are familiar with the proceedings taken by the Board of Directors of the Company (the “Board of Directors”) in connection with the authorization, issuance and sale of the Shares.  We have examined all such documents as we considered necessary to enable us to render this opinion, including but not limited to the Registration Statement, the Prospectus, the Purchase Agreement, the Registration Rights Agreement, dated October 8, 2015 between the Company and the Selling Stockholder, the Company’s Tenth Amended and Restated Certificate of Incorporation and the Amended and Restated Bylaws, as in effect on the date hereof, certain resolutions of the Board of Directors, corporate records and instruments, and such laws and regulations as we have deemed necessary for purposes of rendering the opinions set forth herein.

 

In our examination, we have assumed: (a) the legal capacity of all natural persons; (b) the genuineness of all signatures; (c) the authenticity of all documents submitted to us as originals; (d) the conformity to original documents of all documents submitted to us as certified, conformed, photostatic or facsimile copies; (e) the authenticity of the originals of such latter documents; (f) the truth, accuracy and completeness of the information, representations and warranties contained in the records, documents, instruments, certificates and records we have reviewed; and (g) the absence of any undisclosed modifications to the agreements and instruments reviewed by us.  As to any facts material to the opinions expressed herein, which were not independently established or verified, we have relied upon statements and representations of officers and other representatives of the Company and others.

 

We express no opinion herein as to the law of any state or jurisdiction other than the laws of the State of Delaware, including statutory provisions and all applicable provisions of the Delaware Constitution and reported judicial decisions interpreting such laws of the State of Delaware, and the federal laws of the United States of America.

 

Philadelphia              Boston              Washington, D.C.              Los Angeles              New York              Pittsburgh

 

Detroit              Berwyn              Harrisburg              Orange County              Princeton              Silicon Valley              Wilmington

 

www.pepperlaw.com

 



 

Based upon and subject to the foregoing, we are of the opinion that, as of the date hereof:

 

1.                                      The Outstanding Shares are legally issued, fully paid and nonassessable.

 

2.                                      The Issuable Shares, when issued and paid for in accordance with the Purchase Agreement, will be legally issued, fully paid and nonassessable.

 

We assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinion expressed herein after the date hereof.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Act and to the reference of our firm under the caption “Legal Matters” in the Prospectus.  In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission.  Except as otherwise set forth herein, this opinion may not be used, circulated, quoted or otherwise referred to for any purpose without the express written permission of this firm.

 

 

Very truly yours,

 

 

 

/s/ Pepper Hamilton LLP

 

Pepper Hamilton LLP

 

2